Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL LAURANE ANGLARD PHARMACIEN : revenue, balance sheet and financial ratios

SPFPL LAURANE ANGLARD PHARMACIEN is a French company founded 2 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in LES CONTAMINES-MONTJOIE (74170), this company of category PME shows in 2025 a net income positive of 99 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL LAURANE ANGLARD PHARMACIEN (SIREN 979953072)
Indicator 2025 2024
Revenue N/C N/C
Net income 98 851 € 27 739 €
EBITDA -5 863 € -89 274 €
Net margin N/C N/C

Revenue and income statement

In 2025, SPFPL LAURANE ANGLARD PHARMACIEN generates positive net income of 99 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2024-2025: 28 k€ -> 99 k€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-5 863 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-5 863 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

98 851 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1112%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 8%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 15.4 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1111.587%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

8.229%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

15.36

Solvency indicators evolution
SPFPL LAURANE ANGLARD PHARMACIEN

Sector positioning

Debt ratio
1111.59 2025
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Watch

In 2025, the debt ratio of SPFPL LAURANE ANGLARD PHA... (1111.59) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
8.23% 2025
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Average

In 2025, the financial autonomy of SPFPL LAURANE ANGLARD PHA... (8.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
15.36 years 2025
2024
2025
Q1: 0.0 years
Med: 0.77 years
Q3: 6.12 years
Average

In 2025, the repayment capacity of SPFPL LAURANE ANGLARD PHA... (15.36) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 4413.65. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

4413.655

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-1003.138

Liquidity indicators evolution
SPFPL LAURANE ANGLARD PHARMACIEN

Sector positioning

Liquidity ratio
4413.65 2025
2024
2025
Q1: 159.67
Med: 1116.63
Q3: 6512.12
Good +40 pts over 2 years

In 2025, the liquidity ratio of SPFPL LAURANE ANGLARD PHA... (4413.65) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-1003.14x 2025
2024
2025
Q1: -191.54x
Med: -25.42x
Q3: 0.0x
Average -21 pts over 2 years

In 2025, the interest coverage of SPFPL LAURANE ANGLARD PHA... (-1003.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of SPFPL LAURANE ANGLARD PHARMACIEN in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Based on 170 transactions of similar company sales (all years), the value of SPFPL LAURANE ANGLARD PHARMACIEN is estimated at 1 024 768 € (range 635 207€ - 1 593 838€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
170 transactions
635k€ 1024k€ 1593k€
1 024 768 € Range: 635 207€ - 1 593 838€
NAF 5 all-time

Valuation method used

Net Income Multiple
98 851 € × 10.4x = 1 024 769 €
Range: 635 208€ - 1 593 838€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPL LAURANE ANGLARD PHARMACIEN with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about SPFPL LAURANE ANGLARD PHARMACIEN

What is the revenue of SPFPL LAURANE ANGLARD PHARMACIEN ?

The revenue of SPFPL LAURANE ANGLARD PHARMACIEN is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL LAURANE ANGLARD PHARMACIEN profitable?

Yes, SPFPL LAURANE ANGLARD PHARMACIEN generated a net profit of 99 k€ in 2025.

Where is the headquarters of SPFPL LAURANE ANGLARD PHARMACIEN ?

The headquarters of SPFPL LAURANE ANGLARD PHARMACIEN is located in LES CONTAMINES-MONTJOIE (74170), in the department Haute-Savoie.

Where to find the tax return of SPFPL LAURANE ANGLARD PHARMACIEN ?

The tax return of SPFPL LAURANE ANGLARD PHARMACIEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL LAURANE ANGLARD PHARMACIEN operate?

SPFPL LAURANE ANGLARD PHARMACIEN operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.